Peptide record

TPDB20171

Antibacterial Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20171
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 24-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
GIYTGRLLPVYIPQPRPPHPRLRR
Physicochemical Analysis
C132H214N42O29
ANDCEKMFSW
P
2853.42
12.23
6
0
8
+5
4.34
-0.763
93.33
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
2980
104.44
4
Residue Composition
number
0
A
5
R
0
N
0
D
0
C
0
E
1
Q
2
G
1
H
2
I
3
L
0
K
0
M
0
F
6
P
0
S
1
T
0
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 5 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 2 H: 1 I: 2 L: 3 K: 0 M: 0 F: 0 P: 6 S: 0 T: 1 W: 0 Y: 2 V: 1
Chemical Descriptors
24
C132H214N42O29
2853.42
12.23
+5
4.34
-0.763
Evidence Records 4 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4-8 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 4-8 ug/ml), S. enteritidis (MIC 16-32 ug/ml), and S.aureus ATCC 29213 (MIC>128 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
16-32 µg/mL

Target

S. enteritidis

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 4-8 ug/ml), S. enteritidis (MIC 16-32 ug/ml), and S.aureus ATCC 29213 (MIC>128 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
>128 µg/mL

Target

S.aureus ATCC 29213

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 4-8 ug/ml), S. enteritidis (MIC 16-32 ug/ml), and S.aureus ATCC 29213 (MIC>128 ug/ml).
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
>128 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >128 | µg/mL | target cell: Pig erythrocytes

Target

Pig erythrocytes

Source & Reference

NA
DBAASP
Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects. | Antibiotics (Basel) | 2022